Bone morphogenetic protein (BMP) signalling plays a pivotal role in bone regeneration by regulating osteoprogenitor cell (OPC) function, and BMPs have been widely used in clinical treatment. However, their limited specificity for OPCs often lead to side effects, highlighting that the regulatory mechanisms of BMP signalling remain to be further elucidated. BMPR1A, a key type I BMP receptor, has emerged as a critical regulator of bone development, yet its precise role in bone regeneration and downstream mechanisms remains unclear. Using OPC-specific conditional knockout (cKO) and constitutively activated (CA) BMPR1A mouse, we found conditional knockout of BMPR1A in OPCs during the first 2 weeks of healing significantly accelerated bone regeneration. At the cellular level, BMPR1A knockout promoted the proliferation of OPCs, thereby accelerating bone regeneration in cKO mice. Mechanistically, BMPR1A knockout reduced ID1 expression, releasing its inhibition of TCF3, which in turn induced GNG4 expression and ultimately activated the PI3K–AKT pathway. Finally, a double-knockdown cell line further demonstrated the role of the BMPR1A–ID1–TCF3–GNG4 signalling axis. This study reveals the function and mechanism of BMPR1A in bone regeneration and provides new insights for more precise BMP-targeted strategies.
| [1] |
G. N. Duda, S. Geissler, S. Checa, S. Tsitsilonis, A. Petersen, and K. Schmidt-Bleek, “The Decisive Early Phase of Bone Regeneration,” Nature Reviews Rheumatology 19, no. 2 (2023): 78–95, https://doi.org/10.1038/s41584-022-00887-0.
|
| [2] |
L. Claes, S. Recknagel, and A. Ignatius, “Fracture Healing Under Healthy and Inflammatory Conditions,” Nature Reviews Rheumatology 8, no. 3 (2012): 133–143, https://doi.org/10.1038/nrrheum.2012.1.
|
| [3] |
D. Trompet, S. Melis, A. S. Chagin, and C. Maes, “Skeletal Stem and Progenitor Cells in Bone Development and Repair,” Journal of Bone and Mineral Research 39, no. 6 (2024): 633–654, https://doi.org/10.1093/jbmr/zjae069.
|
| [4] |
Y. Weng, H. Wang, D. Wu, et al., “A Novel Lineage of Osteoprogenitor Cells With Dual Epithelial and Mesenchymal Properties Govern Maxillofacial Bone Homeostasis and Regeneration After MSFL,” Cell Research 32, no. 9 (2022): 814–830, https://doi.org/10.1038/s41422-022-00687-x.
|
| [5] |
A. W. James, G. LaChaud, J. Shen, et al., “A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2,” Tissue Engineering. Part B, Reviews 22, no. 4 (2016): 284–297, https://doi.org/10.1089/ten.TEB.2015.0357.
|
| [6] |
S. Donsante, B. Palmisano, M. Serafini, P. G. Robey, A. Corsi, and M. Riminucci, “From Stem Cells to Bone-Forming Cells,” International Journal of Molecular Sciences 22, no. 8 (2021): 3989, https://doi.org/10.3390/ijms22083989.
|
| [7] |
M. S. Rahman, N. Akhtar, H. M. Jamil, R. S. Banik, and S. M. Asaduzzaman, “TGF-Beta/BMP Signaling and Other Molecular Events: Regulation of Osteoblastogenesis and Bone Formation,” Bone Research 3 (2015): 15005, https://doi.org/10.1038/boneres.2015.5.
|
| [8] |
X. Long, D. Tan, Q. Tao, et al., “Application Strategies of Bone Marrow Mesenchymal Stromal Cells in Bone-Related Diseases,” Cell Proliferation 59, no. 4 (2026): e70178, https://doi.org/10.1111/cpr.70178.
|
| [9] |
W. R. Otto and J. Rao, “Tomorrow's Skeleton Staff: Mesenchymal Stem Cells and the Repair of Bone and Cartilage,” Cell Proliferation 37, no. 1 (2004): 97–110, https://doi.org/10.1111/j.1365-2184.2004.00303.x.
|
| [10] |
K. Tsuji, A. Bandyopadhyay, B. D. Harfe, et al., “BMP2 Activity, Although Dispensable for Bone Formation, Is Required for the Initiation of Fracture Healing,” Nature Genetics 38, no. 12 (2006): 1424–1429, https://doi.org/10.1038/ng1916.
|
| [11] |
M. Wu, S. Wu, W. Chen, and Y. P. Li, “The Roles and Regulatory Mechanisms of TGF-Beta and BMP Signaling in Bone and Cartilage Development, Homeostasis and Disease,” Cell Research 34, no. 2 (2024): 101–123, https://doi.org/10.1038/s41422-023-00918-9.
|
| [12] |
V. S. Salazar, L. W. Gamer, and V. Rosen, “BMP Signalling in Skeletal Development, Disease and Repair,” Nature Reviews. Endocrinology 12, no. 4 (2016): 203–221, https://doi.org/10.1038/nrendo.2016.12.
|
| [13] |
J. W. Lowery and V. Rosen, “The BMP Pathway and Its Inhibitors in the Skeleton,” Physiological Reviews 98, no. 4 (2018): 2431–2452, https://doi.org/10.1152/physrev.00028.2017.
|
| [14] |
S. Lin, K. K. Svoboda, J. Q. Feng, and X. Jiang, “The Biological Function of Type I Receptors of Bone Morphogenetic Protein in Bone,” Bone Research 4 (2016): 16005, https://doi.org/10.1038/boneres.2016.5.
|
| [15] |
E. M. Shore, M. Xu, G. J. Feldman, et al., “A Recurrent Mutation in the BMP Type I Receptor ACVR1 Causes Inherited and Sporadic Fibrodysplasia Ossificans Progressiva,” Nature Genetics 38, no. 5 (2006): 525–527, https://doi.org/10.1038/ng1783.
|
| [16] |
T. Maruyama, R. Stevens, A. Boka, et al., “BMPR1A Maintains Skeletal Stem Cell Properties in Craniofacial Development and Craniosynostosis,” Science Translational Medicine 13, no. 583 (2021): eabb4416, https://doi.org/10.1126/scitranslmed.abb4416.
|
| [17] |
S. Keller, J. Nickel, J. L. Zhang, W. Sebald, and T. D. Mueller, “Molecular Recognition of BMP-2 and BMP Receptor IA,” Nature Structural & Molecular Biology 11, no. 5 (2004): 481–488, https://doi.org/10.1038/nsmb756.
|
| [18] |
T. Kirsch, W. Sebald, and M. K. Dreyer, “Crystal Structure of the BMP-2-BRIA Ectodomain Complex,” Nature Structural Biology 7, no. 6 (2000): 492–496, https://doi.org/10.1038/75903.
|
| [19] |
Y. Guo, Y. Yuan, L. Wu, et al., “BMP-IHH-Mediated Interplay Between Mesenchymal Stem Cells and Osteoclasts Supports Calvarial Bone Homeostasis and Repair,” Bone Research 6 (2018): 30, https://doi.org/10.1038/s41413-018-0031-x.
|
| [20] |
Q. Bao, A. Li, S. Chen, et al., “Disruption of Bone Morphogenetic Protein Type IA Receptor in Osteoblasts Impairs Bone Quality and Bone Strength in Mice,” Cell and Tissue Research 374, no. 2 (2018): 263–273, https://doi.org/10.1007/s00441-018-2873-3.
|
| [21] |
I. Kalajzic, Z. Kalajzic, M. Kaliterna, et al., “Use of Type I Collagen Green Fluorescent Protein Transgenes to Identify Subpopulations of Cells at Different Stages of the Osteoblast Lineage,” Journal of Bone and Mineral Research 17, no. 1 (2002): 15–25, https://doi.org/10.1359/jbmr.2002.17.1.15.
|
| [22] |
Z. Kalajzic, P. Liu, I. Kalajzic, et al., “Directing the Expression of a Green Fluorescent Protein Transgene in Differentiated Osteoblasts: Comparison Between Rat Type I Collagen and Rat Osteocalcin Promoters,” Bone 31, no. 6 (2002): 654–660, https://doi.org/10.1016/s8756-3282(02)00912-2.
|
| [23] |
Y. Mishina, M. C. Hanks, S. Miura, M. D. Tallquist, and R. R. Behringer, “Generation of Bmpr/Alk3 Conditional Knockout Mice,” Genesis 32, no. 2 (2002): 69–72, https://doi.org/10.1002/gene.10038.
|
| [24] |
R. Wieser, J. L. Wrana, and J. Massague, “GS Domain Mutations That Constitutively Activate T Beta R-I, the Downstream Signaling Component in the TGF-Beta Receptor Complex,” EMBO Journal 14, no. 10 (1995): 2199–2208, https://doi.org/10.1002/j.1460-2075.1995.tb07214.x.
|
| [25] |
Y. Komatsu, P. B. Yu, N. Kamiya, et al., “Augmentation of Smad-Dependent BMP Signaling in Neural Crest Cells Causes Craniosynostosis in Mice,” Journal of Bone and Mineral Research 28, no. 6 (2013): 1422–1433, https://doi.org/10.1002/jbmr.1857.
|
| [26] |
F. Zhang, M. Lv, S. Wang, et al., “Ultrasound-Triggered Biomimetic Ultrashort Peptide Nanofiber Hydrogels Promote Bone Regeneration by Modulating Macrophage and the Osteogenic Immune Microenvironment,” Bioactive Materials 31 (2024): 231–246, https://doi.org/10.1016/j.bioactmat.2023.08.008.
|
| [27] |
G. S. Gulati, M. P. Murphy, O. Marecic, et al., “Isolation and Functional Assessment of Mouse Skeletal Stem Cell Lineage,” Nature Protocols 13, no. 6 (2018): 1294–1309, https://doi.org/10.1038/nprot.2018.041.
|
| [28] |
M. N. Michalski and B. O. Williams, “The Past, Present, and Future of Genetically Engineered Mouse Models for Skeletal Biology,” Biomolecules 13, no. 9 (2023): 1311, https://doi.org/10.3390/biom13091311.
|
| [29] |
T. A. Einhorn and L. C. Gerstenfeld, “Fracture Healing: Mechanisms and Interventions,” Nature Reviews Rheumatology 11, no. 1 (2015): 45–54, https://doi.org/10.1038/nrrheum.2014.164.
|
| [30] |
D. S. Amarasekara, S. Kim, and J. Rho, “Regulation of Osteoblast Differentiation by Cytokine Networks,” International Journal of Molecular Sciences 22, no. 6 (2021): 2581, https://doi.org/10.3390/ijms22062851.
|
| [31] |
K. Vermeulen, Z. N. Berneman, and D. R. Van Bockstaele, “Cell Cycle and Apoptosis,” Cell Proliferation 36, no. 3 (2003): 165–175, https://doi.org/10.1046/j.1365-2184.2003.00267.x.
|
| [32] |
K. Vermeulen, D. R. Van Bockstaele, and Z. N. Berneman, “The Cell Cycle: A Review of Regulation, Deregulation and Therapeutic Targets in Cancer,” Cell Proliferation 36, no. 3 (2003): 131–149, https://doi.org/10.1046/j.1365-2184.2003.00266.x.
|
| [33] |
W. Huang, X. Wu, S. Xiang, et al., “Regulatory of miRNAs in Tri-Lineage Differentiation of C3H10T1/2,” Stem Cell Research & Therapy 13, no. 1 (2022): 521, https://doi.org/10.1186/s13287-022-03205-3.
|
| [34] |
C. Kaps, A. Hoffmann, Y. Zilberman, et al., “Distinct Roles of BMP Receptors Type IA and IB in Osteo−/Chondrogenic Differentiation in Mesenchymal Progenitors (C3H10T1/2),” BioFactors 20, no. 2 (2004): 71–84, https://doi.org/10.1002/biof.5520200202.
|
| [35] |
J. Abe, “Bone Morphogenetic Protein (BMP) Family, SMAD Signaling and id Helix-Loop-Helix Proteins in the Vasculature: The Continuous Mystery of BMPs Pleotropic Effects,” Journal of Molecular and Cellular Cardiology 41, no. 1 (2006): 4–7, https://doi.org/10.1016/j.yjmcc.2006.04.012.
|
| [36] |
L. H. Wang and N. E. Baker, “E Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and Disease,” Developmental Cell 35, no. 3 (2015): 269–280, https://doi.org/10.1016/j.devcel.2015.10.019.
|
| [37] |
H. W. Lee, T. Adachi, B. Pak, et al., “BMPR1A Promotes ID2-ZEB1 Interaction to Suppress Excessive Endothelial to Mesenchymal Transition,” Cardiovascular Research 119, no. 3 (2023): 813–825, https://doi.org/10.1093/cvr/cvac159.
|
| [38] |
G. Hoxhaj and B. D. Manning, “The PI3K-AKT Network at the Interface of Oncogenic Signalling and Cancer Metabolism,” Nature Reviews. Cancer 20, no. 2 (2020): 74–88, https://doi.org/10.1038/s41568-019-0216-7.
|
| [39] |
K. Luo, “Signaling Cross Talk Between TGF-Beta/Smad and Other Signaling Pathways,” Cold Spring Harbor Perspectives in Biology 9, no. 1 (2017): a022137, https://doi.org/10.1101/cshperspect.a022137.
|
| [40] |
Y. He, M. M. Sun, G. G. Zhang, et al., “Targeting PI3K/Akt Signal Transduction for Cancer Therapy,” Signal Transduction and Targeted Therapy 6, no. 1 (2021): 425, https://doi.org/10.1038/s41392-021-00828-5.
|
| [41] |
S. E. Desale, H. Chidambaram, and S. Chinnathambi, “G-Protein Coupled Receptor, PI3K and Rho Signaling Pathways Regulate the Cascades of Tau and Amyloid-Beta in Alzheimer's Disease,” Molecular Biomedicine 2, no. 1 (2021): 17, https://doi.org/10.1186/s43556-021-00036-1.
|
| [42] |
S. Kalyanaraman, N. G. Copeland, D. G. Gilbert, N. A. Jenkins, and N. Gautam, “Structure and Chromosomal Localization of Mouse G Protein Subunit Gamma 4 Gene,” Genomics 49, no. 1 (1998): 147–151, https://doi.org/10.1006/geno.1998.5223.
|
| [43] |
N. Kamiya, L. Ye, T. Kobayashi, et al., “Disruption of BMP Signaling in Osteoblasts Through Type IA Receptor (BMPRIA) Increases Bone Mass,” Journal of Bone and Mineral Research 23, no. 12 (2008): 2007–2017, https://doi.org/10.1359/jbmr.080809.
|
| [44] |
N. Kamiya, L. Ye, T. Kobayashi, et al., “BMP Signaling Negatively Regulates Bone Mass Through Sclerostin by Inhibiting the Canonical Wnt Pathway,” Development 135, no. 22 (2008): 3801–3811, https://doi.org/10.1242/dev.025825.
|
| [45] |
H. Zhang, Y. Zhang, M. Terajima, et al., “Loss of BMP Signaling Mediated by BMPR1A in Osteoblasts Leads to Differential Bone Phenotypes in Mice Depending on Anatomical Location of the Bones,” Bone 137 (2020): 115402, https://doi.org/10.1016/j.bone.2020.115402.
|
| [46] |
J. Lim, Y. Shi, C. M. Karner, et al., “Dual Function of Bmpr1a Signaling in Restricting Preosteoblast Proliferation and Stimulating Osteoblast Activity in Mouse,” Development 143, no. 2 (2016): 339–347, https://doi.org/10.1242/dev.126227.
|
| [47] |
N. Kamiya, L. Shuxian, R. Yamaguchi, et al., “Targeted Disruption of BMP Signaling Through Type IA Receptor (BMPR1A) in Osteocyte Suppresses SOST and RANKL, Leading to Dramatic Increase in Bone Mass, Bone Mineral Density and Mechanical Strength,” Bone 91 (2016): 53–63, https://doi.org/10.1016/j.bone.2016.07.002.
|
| [48] |
Y. Mishina, M. W. Starbuck, M. A. Gentile, et al., “Bone Morphogenetic Protein Type IA Receptor Signaling Regulates Postnatal Osteoblast Function and Bone Remodeling,” Journal of Biological Chemistry 279, no. 26 (2004): 27560–27566, https://doi.org/10.1074/jbc.M404222200.
|
| [49] |
M. Okamoto, J. Murai, Y. Imai, et al., “Conditional Deletion of Bmpr1a in Differentiated Osteoclasts Increases Osteoblastic Bone Formation, Increasing Volume of Remodeling Bone in Mice,” Journal of Bone and Mineral Research 26, no. 10 (2011): 2511–2522, https://doi.org/10.1002/jbmr.477.
|
| [50] |
B. Heubel and A. Nohe, “The Role of BMP Signaling in Osteoclast Regulation,” Journal of Developmental Biology 9, no. 3 (2021): 24, https://doi.org/10.3390/jdb9030024.
|
| [51] |
W. Hu, Y. Xin, J. Hu, Y. Sun, and Y. Zhao, “Inhibitor of DNA Binding in Heart Development and Cardiovascular Diseases,” Cell Communication and Signaling: CCS 17, no. 1 (2019): 51, https://doi.org/10.1186/s12964-019-0365-z.
|
| [52] |
M. Genander, P. J. Cook, D. Ramskold, et al., “BMP Signaling and Its pSMAD1/5 Target Genes Differentially Regulate Hair Follicle Stem Cell Lineages,” Cell Stem Cell 15, no. 5 (2014): 619–633, https://doi.org/10.1016/j.stem.2014.09.009.
|
| [53] |
H. Chen, M. Zhang, J. Li, et al., “BMP9-ID1 Pathway Attenuates N(6)-Methyladenosine Levels of CyclinD1 to Promote Cell Proliferation in Hepatocellular Carcinoma,” International Journal of Molecular Sciences 25, no. 2 (2024): 981, https://doi.org/10.3390/ijms25020981.
|
| [54] |
C. G. Kantzer, W. Yang, D. Grommisch, et al., “ID1 and CEBPA Coordinate Epidermal Progenitor Cell Differentiation,” Development 149, no. 22 (2022): dev201262, https://doi.org/10.1242/dev.201262.
|
| [55] |
O. B. Taylor, S. P. Patel, E. C. Hawthorn, H. M. El-Hodiri, and A. J. Fischer, “ID Factors Regulate the Ability of Muller Glia to Become Proliferating Neurogenic Progenitor-Like Cells,” Glia 72, no. 7 (2024): 1236–1258, https://doi.org/10.1002/glia.24523.
|
| [56] |
R. Rodriguez Viales, N. Diotel, M. Ferg, et al., “The Helix-Loop-Helix Protein id1 Controls Stem Cell Proliferation During Regenerative Neurogenesis in the Adult Zebrafish Telencephalon,” Stem Cells 33, no. 3 (2015): 892–903, https://doi.org/10.1002/stem.1883.
|
| [57] |
F. Tao, J. Soffers, D. Hu, et al., “Beta-Catenin and Associated Proteins Regulate Lineage Differentiation in Ground State Mouse Embryonic Stem Cells,” Stem Cell Reports 15, no. 3 (2020): 662–676, https://doi.org/10.1016/j.stemcr.2020.07.018.
|
| [58] |
H. Nguyen, B. J. Merrill, L. Polak, et al., “Tcf3 and Tcf4 Are Essential for Long-Term Homeostasis of Skin Epithelia,” Nature Genetics 41, no. 10 (2009): 1068–1075, https://doi.org/10.1038/ng.431.
|
| [59] |
J. Wang, Y. Wang, J. Zhou, et al., “GNG4, as a Potential Predictor of Prognosis, Is Correlated With Immune Infiltrates in Colon Adenocarcinoma,” Journal of Cellular and Molecular Medicine 27, no. 17 (2023): 2517–2532, https://doi.org/10.1111/jcmm.17847.
|
| [60] |
X. Jiang, F. Tang, J. Zhang, et al., “High GNG4 Predicts Adverse Prognosis for Osteosarcoma: Bioinformatics Prediction and Experimental Verification,” Frontiers in Oncology 13 (2023): 991483, https://doi.org/10.3389/fonc.2023.991483.
|
| [61] |
L. Duan, X. Liu, Z. Luo, et al., “G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer,” Genes (Basel) 13, no. 4 (2022): 693, https://doi.org/10.3390/genes13040693.
|
| [62] |
H. Tanaka, M. Kanda, T. Miwa, et al., “G-Protein Subunit Gamma-4 Expression Has Potential for Detection, Prediction and Therapeutic Targeting in Liver Metastasis of Gastric Cancer,” British Journal of Cancer 125, no. 2 (2021): 220–228, https://doi.org/10.1038/s41416-021-01366-1.
|
| [63] |
J. J. Zhang, J. Hong, Y. S. Ma, et al., “Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression,” Disease Markers 14 (2021): 6696198, https://doi.org/10.1155/2021/6696198.
|
| [64] |
A. Julien, S. Perrin, E. Martinez-Sarra, et al., “Skeletal Stem/Progenitor Cells in Periosteum and Skeletal Muscle Share a Common Molecular Response to Bone Injury,” Journal of Bone and Mineral Research 37, no. 8 (2022): 1545–1561, https://doi.org/10.1002/jbmr.4616.
|
Rights & permissions
2026 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.
PDF
(22880KB)
